Literature DB >> 7891098

Free radical-generated neurotoxicity of 6-hydroxydopamine.

R Kumar1, A K Agarwal, P K Seth.   

Abstract

Albino rats were lesioned bilaterally with 6-hydroxydopamine (6-OHDA) hydrochloride (4 micrograms/microliters, dissolved in saline with 0.1% ascorbic acid) into the striatum, and 72 h after the injection, levels of lipid peroxidation, GSH, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), lipid class, membrane fluidity, and intracellular calcium concentrations were studied and the results were compared with those in the sham-operated controls. The malonaldialdehyde level and the level of conjugated dienes were increased by 43 and 40%, respectively, in corpus striatum, and GSH, SOD, and GSH-Px levels were decreased (24-30%) following 6-OHDA treatment. Total phospholipid content was also decreased (18%), whereas cholesterol content remained unaffected. Among the different phospholipids only phosphatidylcholine and phosphatidylinositol were decreased in level. Membrane fluidity was decreased (23%), whereas the intracellular calcium concentration was elevated (100%) in corpus striatum compared with control rats. The results suggest that these alterations in membrane-related events by 6-OHDA could be due to free radical generation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891098     DOI: 10.1046/j.1471-4159.1995.64041703.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons.

Authors:  Myung S Yoo; Hibiki Kawamata; Dae J Kim; Hong S Chun; Jin H Son
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity.

Authors:  H Kabuto; I Yokoi; E Iwata-Ichikawa; N Ogawa
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

4.  Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.

Authors:  M P Smith; W A Cass
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

Review 5.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation.

Authors:  Min-Kyoung Kim; Sang-Cheol Kim; Jung-Il Kang; Jae-Hee Hyun; Hye-Jin Boo; Su-Yong Eun; Deok-Bae Park; Eun-Sook Yoo; Hee-Kyoung Kang; Ji-Hoon Kang
Journal:  Neurochem Res       Date:  2010-11-06       Impact factor: 3.996

7.  Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system.

Authors:  J M Masserano; I Baker; D Venable; L Gong; S J Zullo; C R Merril; R J Wyatt
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

8.  Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta.

Authors:  Rebecca L Cunningham; Andrea Giuffrida; James L Roberts
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

9.  Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.

Authors:  Hideaki Kabuto; Masao Amakawa; Mitsumasa Mankura; Tomoko T Yamanushi; Akitane Mori
Journal:  Neurochem Res       Date:  2009-02-15       Impact factor: 3.996

10.  Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.

Authors:  Stina Friling; Maria Bergsland; Susanna Kjellander
Journal:  BMC Neurosci       Date:  2009-12-11       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.